CD Antigen Cancer Therapy Market by Key
Segments | Forecast Years:
2022-
2027
{reportSlug=global-cd-antigen-cancer-therapy-market, reportId=12719, mktKeyword=CD Antigen Cancer Therapy, cagr=0.00, publishDate=Mar 2022, priceOption2=6800, reportTitle=CD Antigen Cancer Therapy Comprehensive Study by Type (Monoclonal Antibodies, Antibody-Drug-Conjugates, Tri-Functional & Bi-Specific T-Cell Engager Antibodies, Other), Application (Hospitals, Homecare, Specialty Clinics, Others), Drugs Type (Rituximab, Ocrelizumab, Ofatumumab, Obinutuzumab, Others), Sales Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy), CD Antigens (CD19, CD20, CD22, CD30, CD33, CD37, CD38, CD70, CD137), Administration Route (Intravenous, Subcutaneous, Others) Players and Region - Global Market Outlook to 2027, baseYr=2021, totalTableFig=212, priceOption1=3750, forecastYr=2027, noOfPages=236, reportKey=12655, breadcrum=Global CD Antigen Cancer Therapy Market}
We do not share your information with anyone. However, we may send you
emails based on your report interest from time to time. You may contact
us at any time to opt-out.
Select User Access Type
Key Highlights of Report
Mar 2022
236 Pages
97 Tables
Base Year: 2021Coverage: 15+ Companies; 18
Countries